1h Free Analyst Time
The in-vitro and in-vivo micro electrode array market is forecasted to grow by USD 7.5 million during 2024-2029, accelerating at a CAGR of 4.4% during the forecast period. The report on the in-vitro and in-vivo micro electrode array market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by extensive use of meas in neuroscience research, wide applications of in vitro cmos-based meas, and rising neurological disorders globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The in-vitro and in-vivo micro electrode array market is segmented as below:
By End-user
- Pharmaceutical
- Academic and other research labs
By Type
- Multiwell MEA
- Single well MEA
By Application
- Neuroscience research
- Drug discovery
- Disease modeling
- Brain-computer interfaces
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the in-vitro and in-vivo micro electrode array market covers the following areas:
- In-Vitro And In-Vivo Micro Electrode Array Market sizing
- In-Vitro And In-Vivo Micro Electrode Array Market forecast
- In-Vitro And In-Vivo Micro Electrode Array Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Type
10 Market Segmentation by Application
11 Customer Landscape
12 Geographic Landscape
13 Drivers, Challenges, and Opportunity/Restraints
14 Competitive Landscape
15 Competitive Analysis
16 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global in-vitro and in-vivo micro electrode array market: 3Brain AG, Alpha Omega Engineering Ltd., Axion BioSystems Inc., Blackrock Microsystems Inc., Cambridge NeuroTech, FHC Inc., Harvard Bioscience Inc., IMEC Inc., Innovative Neurophysiology Inc., MaxWell Biosystems AG, Microprobes for Life Science, MICRUX FLUIDIC S.L., NeuroNexus Technologies Inc., NMI Technologie Transfer GmbH, Plexon Inc., Ripple Neuro, Screen Holdings Co. Ltd., SpikeGadgets, Tucker Davis Technologies Inc., and World Precision Instruments.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is potential application of in-vitro and in-vivo mea in cancer tissue detection."
According to the report, one of the major drivers for this market is the extensive use of meas in neuroscience research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3Brain AG
- Alpha Omega Engineering Ltd.
- Axion BioSystems Inc.
- Blackrock Microsystems Inc.
- Cambridge NeuroTech
- FHC Inc.
- Harvard Bioscience Inc.
- IMEC Inc.
- Innovative Neurophysiology Inc.
- MaxWell Biosystems AG
- Microprobes for Life Science
- MICRUX FLUIDIC S.L.
- NeuroNexus Technologies Inc.
- NMI Technologie Transfer GmbH
- Plexon Inc.
- Ripple Neuro
- Screen Holdings Co. Ltd.
- SpikeGadgets
- Tucker Davis Technologies Inc.
- World Precision Instruments
